A clinical study to know the effectiveness of a medicine called magnesium sulphate for epidural anaesthesia in reducing pain during normal delivery

Phase 4

• Conditions: Health Condition 1: O80- Encounter for full-term uncomplicated delivery

• Registration Number: CTRI/2019/08/020679
• Lead Sponsor: Srinivas Institute of Medical Sciences and Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Parturients in age group of 18 â?? 35yrs for planned vaginal delivery.

2. Parturients in first stage of labour with cervical dilatation greater than or equal to 3cms.

3. Parturients in height range of 145 â?? 175 cms and in weight range of 50 â?? 100 kgs.

Exclusion Criteria

1.Pregnant patient not consenting for study.

2.History of allergy to local anesthetics.

3.Coagulation abnormality.

4.Infection at the site of the injection.

5.Any abnormality or disease of the spine.

6.Patient with any uncontrolled systemic illness.

7.Parturient with pre-eclampsia and eclampsia who received IV Magnesium for obstetric management.

8.Parturients with cardiac diseases.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the effectiveness and quality of labour analgesia with and without epidural bolus dose of 25 mg of magnesium sulphate along with intrathecal fentanyl ( 15 mcg ) and epidural bupivacaine infusion ( 0.1 % ).Timepoint: Patients vitals parameters will be assessed at baseline, 5, 15, 30, 60, 90 and 120 min and labour pain score and fetal well being will be assessed till the delivery

Secondary Outcome Measures

Name	Time	Method
Hypotension, motor block, itching, nausea and vomitingTimepoint: At baseline, 5, 15, 30, 60, 90 and 120 min and till the time of delivery